Skip to content

Tango Therapeutics TNGX Compensation and benefits

Compensation and benefits at other companies

Lantheus Holdings logo
Lantheus HoldingsLNTH
Tempus AI, Inc. logo
Tempus AI, Inc.TEM
Roivant Sciences logo
Roivant SciencesROIV
Incyte logo
IncyteINCY
Eli Lilly logo
Eli LillyLLY
Moderna logo
ModernaMRNA

Other financials

Income statement

See full
Revenue--100%
Operating income-$48.8M-14.7%
Net income-$45.5M-14.1%
EPS (diluted)-$0.32+11.1%

Balance sheet

See full
Cash & equivalents$160.0M+162%
Total debt$32.8M-11.3%
Total equity$391.5M+135%
Total assets$435.8M+58.9%

Cash flow

See full
Operating cash flow-$44.4M-6.4%
CapEx-$2.0K-104%
Free cash flow-$44.4M-6.3%

Valuation

See full
Market cap$4.55B+1,915%

Profitability

See full
Operating margin-206.2%-61.0pp
Net margin-188.2%-55.4pp
FCF margin-250.1%-49.4pp

Returns & leverage

See full
Return on equity-38.4%-10.5pp
Debt / equity0.1×-0.1×
Current ratio27.4×+21.1×

Where this comes from

Reported directly by Tango Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.

The official record: Tango Therapeutics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Tango Therapeutics's compensation and benefits.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Tango Therapeutics's compensation and benefits?
Tango Therapeutics (TNGX) reported compensation and benefits of $3.24M in Q1 2026.
How has Tango Therapeutics's compensation and benefits changed year-over-year?
Tango Therapeutics's compensation and benefits increased by 1.9% year-over-year, from $3.18M to $3.24M.
What is the long-term trend for Tango Therapeutics's compensation and benefits?
Over 5 years (2020 to 2025), Tango Therapeutics's compensation and benefits has grown at a 27.8% compound annual growth rate (CAGR), from $2.65M to $9.05M.